leadf
logo-loader

Proactive events

Proactive Investors One2One Investor Forum

9 July 2020 | London

This event is now taking place in webinar format

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

1508314642_sil.png
Silence Therapeutics PLC

Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with...

1557485123_open_orphan.png
Open Orphan PLC

Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials.. It has Europe's only 24-bedroom quarantine...

1585306761_MaxCyte.png
MaxCyte Inc

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

ixico-logo.png
IXICO PLC

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.